Silence Therapeutics (SLN) Shares Outstanding: 2019-2025
Historic Shares Outstanding for Silence Therapeutics (SLN) over the last 5 years, with Sep 2025 value amounting to $141.7 million.
- Silence Therapeutics' Shares Outstanding fell 23.00% to $141.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $141.7 million, marking a year-over-year decrease of 23.00%. This contributed to the annual value of $141.7 million for FY2024, which is 3.95% down from last year.
- Silence Therapeutics' Shares Outstanding amounted to $141.7 million in Q3 2025, which was down 0.00% from $141.7 million recorded in Q2 2025.
- Over the past 5 years, Silence Therapeutics' Shares Outstanding peaked at $146.9 billion during Q3 2023, and registered a low of $121.0 million during Q4 2021.
- In the last 3 years, Silence Therapeutics' Shares Outstanding had a median value of $177.2 million in 2024 and averaged $38.0 billion.
- As far as peak fluctuations go, Silence Therapeutics' Shares Outstanding crashed by 90.41% in 2022, and later skyrocketed by 3,308.29% in 2023.
- Silence Therapeutics' Shares Outstanding (MRQ) stood at $121.0 million in 2021, then increased by 4.48% to $126.5 million in 2022, then rose by 16.65% to $147.5 million in 2023, then fell by 3.95% to $141.7 million in 2024, then grew by 0.02% to $141.7 million in 2025.
- Its last three reported values are $141.7 million in Q3 2025, $141.7 million for Q2 2025, and $141.7 million during Q1 2025.